These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 16368700)

  • 1. Enhanced efficacy of pH-sensitive nystatin liposomes against Cryptococcus neoformans in murine model.
    Nasti TH; Khan MA; Owais M
    J Antimicrob Chemother; 2006 Feb; 57(2):349-52. PubMed ID: 16368700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incorporation of amphotericin B in tuftsin-bearing liposomes showed enhanced efficacy against systemic cryptococcosis in leucopenic mice.
    Khan MA; Nasti TH; Owais M
    J Antimicrob Chemother; 2005 Oct; 56(4):726-31. PubMed ID: 16126780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced anticryptococcal activity of chloroquine in phosphatidylserine-containing liposomes in a murine model.
    Khan MA; Jabeen R; Nasti TH; Mohammad O
    J Antimicrob Chemother; 2005 Feb; 55(2):223-8. PubMed ID: 15590713
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune stimulating and therapeutic potential of tuftsin-incorporated nystatin liposomes against Cryptococcus neoformans in leukopenic BALB/C mice.
    Khan MA; Aljarbou A; Khan A; Owais M
    FEMS Immunol Med Microbiol; 2012 Oct; 66(1):88-97. PubMed ID: 22612788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of amphotericin B in combination with flucytosine against flucytosine-susceptible or flucytosine-resistant isolates of Cryptococcus neoformans during disseminated murine cryptococcosis.
    Schwarz P; Dromer F; Lortholary O; Dannaoui E
    Antimicrob Agents Chemother; 2006 Jan; 50(1):113-20. PubMed ID: 16377675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of voriconazole in a murine model of cryptococcal central nervous system infection.
    Serena C; Pastor FJ; Mariné M; Rodríguez MM; Guarro J
    J Antimicrob Chemother; 2007 Jul; 60(1):162-5. PubMed ID: 17483143
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toxicity, stability and pharmacokinetics of amphotericin B in immunomodulator tuftsin-bearing liposomes in a murine model.
    Khan MA; Owais M
    J Antimicrob Chemother; 2006 Jul; 58(1):125-32. PubMed ID: 16709592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic and hemolytic evaluation of in-situ liposomal preparation containing amphotericin - beta complexed with different chemically modified beta - cyclodextrins.
    Chakraborty KK; Naik SR
    J Pharm Pharm Sci; 2003; 6(2):231-7. PubMed ID: 12935435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mannosylated liposomes as carriers for hamycin in the treatment of experimental aspergillosis in Balb/C mice.
    Moonis M; Ahmad I; Bachhawat BK
    J Drug Target; 1993; 1(2):147-55. PubMed ID: 8069553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glyphosate inhibits melanization of Cryptococcus neoformans and prolongs survival of mice after systemic infection.
    Nosanchuk JD; Ovalle R; Casadevall A
    J Infect Dis; 2001 Apr; 183(7):1093-9. PubMed ID: 11237835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential use of liposomal diallyl sulfide in the treatment of experimental murine candidiasis.
    Maroof A; Farazuddin M; Owais M
    Biosci Rep; 2010 Mar; 30(4):223-31. PubMed ID: 19642969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel murine model of cerebral scedosporiosis: lack of efficacy of amphotericin B.
    Capilla J; Mayayo E; Serena C; Pastor FJ; Guarro J
    J Antimicrob Chemother; 2004 Dec; 54(6):1092-5. PubMed ID: 15509616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunomodulator tuftsin increases the susceptibility of Cryptococcus neoformans to liposomal amphotericin B in immunocompetent BALB/c mice.
    Khan MA; Owais M
    J Drug Target; 2005 Aug; 13(7):423-9. PubMed ID: 16308211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Co-administration of immunomodulator tuftsin and liposomised nystatin can combat less susceptible Candida albicans infection in temporarily neutropenic mice.
    Khan MA; Nasti TH; Saima K; Mallick AI; Firoz A; Wajahul H; Ahmad N; Mohammad O
    FEMS Immunol Med Microbiol; 2004 Jul; 41(3):249-58. PubMed ID: 15196575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemotherapeutic activity of liposomal SJA-95: a new polyene macrolide antibiotic in experimental aspergillosis and cryptococcosis.
    Desai SK; Naik SR
    Biomed Pharmacother; 2009 May; 63(4):287-92. PubMed ID: 18848764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prophylactic role of liposomized chloroquine against murine cryptococcosis less susceptible to fluconazole.
    Khan MA; Jabeen R; Mohammad O
    Pharm Res; 2004 Dec; 21(12):2207-12. PubMed ID: 15648251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activity of an Intralipid formulation of nystatin in murine systemic candidiasis.
    Semis R; Mendlovic S; Polacheck I; Segal E
    Int J Antimicrob Agents; 2011 Oct; 38(4):336-40. PubMed ID: 21839619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prophylactic use of liposomized tuftsin enhances the susceptibility of Candida albicans to fluconazole in leukopenic mice.
    Khan MA; Khan A; Owais M
    FEMS Immunol Med Microbiol; 2006 Feb; 46(1):63-9. PubMed ID: 16420598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety, efficacy and pharmacokinetics of tuftsin-loaded nystatin liposomes in murine model.
    Khan MA; Faisal SM; Mohammad O
    J Drug Target; 2006 May; 14(4):233-41. PubMed ID: 16777682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Etanidazole in pH-sensitive liposomes: design, characterization and in vitro/in vivo anti-Trypanosoma cruzi activity.
    Morilla MJ; Montanari J; Frank F; Malchiodi E; Corral R; Petray P; Romero EL
    J Control Release; 2005 Apr; 103(3):599-607. PubMed ID: 15820407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.